Ayushman Bharat to cost Rs 5k cr this year
The government’s mega health insurance scheme Ayushman Bharat — National Health Protection Mission (AB-NHPM) may cost the exchequer around Rs 5,000 crore this year because of the time taken to…
Roche takes Tecentriq hit on survival data
ZURICH: Roche’s hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data…
E-commerce players brace for big battle over online pharma
Bengaluru: Online pharma retail is becoming the next battleground for ecommerce players seeking to build a high-frequency play in India. Flipkart, Amazon, BigBasket and Swiggy are all in exploratory talks…
India launches probe as China co recalls BP drug
MUMBAI: India’s drug controller has initiated an investigation on Thursday against all companies importing key raw material valsartan for commonly used hypertension drugs from Chinese manufacturer Zhejiang Huahai Pharmaceuticals. This…
Kalam Institute of Health Technology (KIHT) completes successful One Year
New Delhi: Kalam Institute of Health Technology (KIHT) completed its scintillating first year on 17th of July. Achievements abound in such a small span of time. It has instilled vibrancy into…
The leader of ‘Healthcare at Home’ concept makes it to the big league
New Delhi: The concept of healthcare at home is catching up fast. The prestigious award to the leader who made home a new hospital speaks a volume. It also underlines…
Post GST, contract pharma manufacturers throng Gujarat
AHMEDABAD: With numerous companies choosing Gujarat to set up their new pharmaceutical plants following the implementation of Goods and Services Tax (GST) contract manufacturers are also making a beeline to…
Govt plans two new labs to test drug samples
NEW DELHI: In a move to ensure safer medicines, the Centre plans to designate two new laboratories — in Mumbai and Chennai — as ‘appellate testing laboratories’, to check drug…
In one stroke, bone marrow transplant can transform the cancer completely: Dr Tarun Verma
Shahid Akhter, editor, ETHealthworld spoke to Dr Tarun Verma, Sr Consultant Haematology and BMT programme, HCG APEX Cancer Centre, Mumbai, to figure out the trends and techniques in bone marrow…
Daiichi Sankyo moves Delhi HC to block Fortis-IHH deal
NEW DELHI: Daiichi Sankyo has approached the Delhi high court to block the $1 billion sale of Fortis Healthcare to Malaysian group IHH Bhd while it enforces an arbitration award…
